These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3557723)

  • 1. Relative deconvolution. An explicit method for bioavailability comparison not requiring intravenous administration.
    Veng-Pedersen P; Miller R
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):10-4. PubMed ID: 3557723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconvolution at steady state: determination of gastrointestinal bioavailability of sustained release theophylline.
    Veng-Pedersen P; Miller R
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):233-7. PubMed ID: 3596848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state kinetics of sustained-release phenylpropanolamine.
    Lönnerholm G; Grahnén A; Lindström B
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):39-41. PubMed ID: 6698658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of bioavailability and pharmacokinetic profiles between Theodur and a new sustained-release theophylline formulation].
    Morishita M; Nagai T; Ishizaki T; Suganuma T; Kushida K; Minegishi A
    Arerugi; 1986 Nov; 35(11):1099-104. PubMed ID: 3827603
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained release products.
    Pentikäinen PJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):213-20. PubMed ID: 3710634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of controlled-release metoclopramide. 1st communication: single dose study.
    Beckett AH; Behrendt WA; Hadzija BW
    Arzneimittelforschung; 1987 Feb; 37(2):221-4. PubMed ID: 3580026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and relative bioavailability of a new oral sustained-release form of mexiletine in healthy subjects].
    Santoni Y; Bruno R; Fornaris M; Egre A; Danays T; Cano JP
    Therapie; 1983; 38(4):341-4. PubMed ID: 6648880
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
    Hasan MM; Najib NM; Muti H
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
    Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
    Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioavailability and cardiovascular safety of Dexatrim (phenylpropanolamine hydrochloride) from a controlled-release caplet.
    Shargel L; Silverman HI; Cohen P; Brisson J; Dennis S
    Biopharm Drug Dispos; 1990 Oct; 11(7):569-83. PubMed ID: 2265237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of a sustained release preparation containing phenylpropanolamine hydrochloride.
    Yamakawa I; Shimomura M; Hattori T; Watanabe S; Tsutsumi J; Shinoda A; Miyake Y
    J Pharmacobiodyn; 1986 Dec; 9(12):947-52. PubMed ID: 3572716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the absorption from three ibuprofen formulations.
    Regazzi BM; Rondanelli R; Ciaroelli L; Bartoli AL; Rampini A
    Int J Clin Pharmacol Res; 1986; 6(6):469-73. PubMed ID: 3804520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.